These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8667051)

  • 1. Technetium-99m-MIBI scintigraphy in pulmonary tuberculosis.
    Onsel C; Sönmezoglu K; Camsari G; Atay S; Cetin S; Erdil YT; Uslu I; Uzun A; Kanmaz B; Sayman HB
    J Nucl Med; 1996 Feb; 37(2):233-8. PubMed ID: 8667051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
    Degirmenci B; Kilinc O; Cirak KA; Capa G; Akpinar O; Halilcolar H; Durak H; Akkoclu A; Derebek E; Ucan ES
    J Nucl Med; 1998 Dec; 39(12):2116-20. PubMed ID: 9867153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-hexakis methoxy isobutyl isonitrile MIBI scintigraphy and bronchoalveolar fluid lactic dehydrogenase in pulmonary tuberculosis.
    Alavi M; Emad AF; Bahtouee M
    Hell J Nucl Med; 2008; 11(2):110-3. PubMed ID: 18815666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc isonitrils biophysical aspects in pulmonary tuberculosis. Part I. In vivo evaluation of 99mTc MIBI and 99mTc Tetrofosmin biophysical localization mechanisms.
    Stefanescu C; Rusu V; Boişteanu D; Azoicai D; Costin M; Oleniuc D; Hurjui M; Sattish P
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):944-9. PubMed ID: 17438905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 99mTc-MIBI scintigraphy in the management of patients with pulmonary tuberculosis.
    Raziei G; Masjedi MR; Fotouhi F; Asli NI; Shafiei B; Javadi H; Assadi M
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):622-9. PubMed ID: 22774403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of technetium-99m-sestamibi in differentiation of active from inactive pulmonary tuberculosis using a single photon emission computed tomography method.
    Ahmadihosseini H; Sadeghi R; Zakavi R; Kakhki VR; Kakhki AH
    Nucl Med Commun; 2008 Aug; 29(8):690-4. PubMed ID: 18753821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
    Myslivecek M; Nekula J; Bacovsky J; Scudla V; Koranda P; Kaminek M
    Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical diagnostic value of simultaneous amplification and testing for the diagnosis of sputum-scarce pulmonary tuberculosis.
    Yan L; Zhang Q; Xiao H
    BMC Infect Dis; 2017 Aug; 17(1):545. PubMed ID: 28779754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
    Pace L; Catalano L; Del Vecchio S; Di Gennaro F; De Renzo A; Sica G; Califano C; Tedesco N; Borrelli G; Rotoli B; Salvatore M
    Eur J Nucl Med; 2001 Mar; 28(3):304-12. PubMed ID: 11315597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
    Alper E; Gurel M; Evrensel T; Ozkocaman V; Akbunar T; Demiray M
    Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-MIBI scintigraphy for early detection of locally recurrent non-small cell lung cancer treated with definitive radiation therapy.
    Furuta M; Nozaki M; Kawashima M; Iimuro M; Kitazumi Y; Okayama A; Natsui S; Hamashima Y; Nagao K
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):982-7. PubMed ID: 12734691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
    Pace L; Catalano L; Pinto A; De Renzo A; Di Gennaro F; Califano C; Del Vecchio S; Rotoli B; Salvatore M
    Eur J Nucl Med; 1998 Jul; 25(7):714-20. PubMed ID: 9662593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. tuberculosis in bronchoalveolar lavage fluid.
    Kibiki GS; Mulder B; van der Ven AJ; Sam N; Boeree MJ; van der Zanden A; Dolmans WM
    Trop Med Int Health; 2007 Oct; 12(10):1210-7. PubMed ID: 17956503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
    Villa G; Balleari E; Carletto M; Grosso M; Clavio M; Piccardo A; Rebella L; Tommasi L; Morbelli S; Peschiera F; Gobbi M; Ghio R
    J Exp Clin Cancer Res; 2005 Sep; 24(3):355-61. PubMed ID: 16270521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-MIBI Lung Scintigraphy in the Assessment of Pulmonary Involvement in Interstitial Lung Disease and Its Comparison With Pulmonary Function Tests and High-Resolution Computed Tomography: A Preliminary Study.
    Bahtouee M; Saberifard J; Javadi H; Nabipour I; Raeisi A; Assadi M; Eftekhari M
    Medicine (Baltimore); 2015 Nov; 94(47):e2082. PubMed ID: 26632717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
    Mele A; Offidani M; Visani G; Marconi M; Cambioli F; Nonni M; Catarini M; Brianzoni E; Berbellini A; Ascoli G; Brunori M; Agostini V; Corvatta L; Isidori A; Spinelli A; Gradari M; Leoni P
    Br J Haematol; 2007 Mar; 136(5):729-35. PubMed ID: 17233770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc isonitrils biophysical aspects in pulmonary tuberculosis. Part II. In vitro evaluation of 99mTc MIBI cellular uptake mechanism.
    Stefănescu C; Rusu V; Azoicăi D; Hurjui I
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):210-5. PubMed ID: 17595869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
    Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
    Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.